Compare ALOT & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALOT | FATE |
|---|---|---|
| Founded | 1969 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.5M | 125.6M |
| IPO Year | 1995 | 2013 |
| Metric | ALOT | FATE |
|---|---|---|
| Price | $15.17 | $2.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.10 |
| AVG Volume (30 Days) | 45.4K | ★ 4.6M |
| Earning Date | 04-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.94 | 29.88 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $150,515,000.00 | $6,646,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.96 | $0.91 |
| 52 Week High | $16.07 | $2.88 |
| Indicator | ALOT | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 67.92 | 52.21 |
| Support Level | $13.44 | $1.00 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.60 | 0.25 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 72.76 | 46.12 |
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Aerospace. It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.